Rexahn Pharmaceuticals Publishes New Preclinical Data for Quinoxalinyl-Piperazine Compounds Jan 25, 2012
Rexahn Pharmaceuticals Secures Approval in Europe to Conduct a First-in-Human Trial of RX-3117 in Solid Tumors Jan 18, 2012
Rexahn Pharmaceuticals Granted US Patent for Novel Anti-cancer Isoquinolinamine Compounds Oct 12, 2011
Rexahn Pharmaceuticals Announces Publication of Study Validating Mechanism of Action of Serdaxin® Oct 3, 2011
Rexahn Pharmaceuticals Completes Patient Enrollment for Archexin Phase II Clinical Trial in Metastatic Pancreatic Cancer Sep 28, 2011
Rexahn Pharmaceuticals to Present at the Rodman & Renshaw 13th Annual Healthcare Conference Sep 8, 2011
Rexahn Pharmaceuticals Announces US Patent Issued for CNS-based Treatment of Sexual Dysfunction Sep 6, 2011
Rexahn Pharmaceuticals Completes Patient Enrollment in Serdaxin Phase IIb Clinical Trial for Major Depressive Disorder Jun 22, 2011